Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Current assets
Cash and cash equivalents	$ 165,660	$ 149,759
Restricted cash	174	1,241
Short-term investments	0	41,952
Accounts receivable, net of allowances for credit losses of $3,945 and $3,234	74,971	51,738
Loans held for sale	212,921	159,587
Prepaid expenses	30,531	33,296
Other current assets	20,514	7,472
Total current assets	504,771	445,045
Property and equipment, net	43,312	46,431
Right-of-use assets, net	26,275	31,763
Mortgage servicing rights, at fair value	2,534	32,171
Long-term investments	0	3,149
Goodwill	461,349	461,349
Intangible assets, net	104,127	123,284
Other assets, noncurrent	8,705	10,456
Total assets	1,151,073	1,153,648
Current liabilities
Accounts payable	14,280	10,507
Accrued and other liabilities	101,040	90,360
Warehouse credit facilities	208,817	151,964
Lease liabilities	13,347	15,609
Total current liabilities	337,484	268,440
Lease liabilities, noncurrent	22,853	29,084
Convertible senior notes, net, noncurrent	571,644	688,737
Deferred tax liabilities	647	264
Term loan	243,646	124,416
Total liabilities	1,176,274	1,110,941
Commitments and contingencies (Note 7)
Series A convertible preferred stock—par value $0.001 per share; 10,000,000 shares authorized; 40,000 shares issued and outstanding at September 30, 2024 and December 31, 2023	39,992	39,959
Stockholders’ (deficit) equity
Common stock—par value $0.001 per share; 500,000,000 shares authorized; 123,945,380 and 117,372,171 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively	124	117
Additional paid-in capital	886,592	826,146
Accumulated other comprehensive loss	(140)	(182)
Accumulated deficit	(951,769)	(823,333)
Total stockholders’ (deficit) equity	(65,193)	2,748
Total liabilities, mezzanine equity, and stockholders’ (deficit) equity	$ 1,151,073	$ 1,153,648